Insulin Sensitizers May Help Ward Off Colorectal Cancer for Diabetes Patients

Insulin sensitizers, such as metformin and thiazolidinediones, may help prevent colon polyps from developing in type 2 diabetes patients, according to research presented at the American Association of Clinical Endocrinologists meeting and published in MedPage Today.

In a retrospective study of more than 132,000 VA patients with type 2 diabetes, researchers found patients taking either metformin or thiazolidinediones had a lower risk of having colorectal polyps. Other medications, including aspirin and non-steroidal anti-inflammatory drugs, were associated with a lower risk of polypectomy.

The researchers also found risk factors for developing polyps in type 2 diabetes patients were increasing age, male gender, non-Hispanic white race and smoking, according to the news report.

Read the news report about insulin sensitizers and colon polyps.

Read other coverage about colorectal cancer:

- Two Samples in FIT Testing Improves Diagnostic Yield Without Affecting Attendance

-
Study: Gastroenterologists More Likely Than Oncologists to Obtain Detailed Family History of Colorectal Cancer

-
Interactive Voice Response System Just as Effective as Nurse Call for Endoscopy Completion

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast